Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154672 · ClinicalTrials.gov registry record
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 1
- Enrollment target
NCT02154672: Completed study, sponsored by Yale University.
NCT02154672 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154672 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the incidence of prostate cancer in men with the BRCa2 gene mutation as an independent indicator for prostate cancer screening.
Primary Outcome
number of patients with a BRCA2 mutation who are diagnosed with prostate cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-11-01 |
What the finished NCT02154672 record still lists
NCT02154672 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02154672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154672 about?
NCT02154672 is a clinical study titled "Prostate Cancer Screening in Men With Germline BRCA2 Mutations". The purpose of this study is to determine the incidence of prostate cancer in men with the BRCa2 gene mutation as an independent indicator for prostate cancer screening.
What is the current status of trial NCT02154672?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2014-05. Estimated completion is 2019-11-01.
Who is sponsoring clinical trial NCT02154672?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia